Cargando…
Delayed Anti-CD3 Therapy Results in Depletion of Alloreactive T Cells and the Dominance of Foxp3(+)CD4(+) Graft Infiltrating Cells
The engineered Fc-nonbinding (crystallizable fragment-nonbinding) CD3 antibody has lower mitogenicity and a precise therapeutic window for disease remission in patients with type 1 diabetes. Before anti-CD3 can be considered for use in transplantation, the most effective timing of treatment relative...
Autores principales: | Goto, R, You, S, Zaitsu, M, Chatenoud, L, Wood, KJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790953/ https://www.ncbi.nlm.nih.gov/pubmed/23750800 http://dx.doi.org/10.1111/ajt.12272 |
Ejemplares similares
-
An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8(+) T Cells
por: Wang, Wei, et al.
Publicado: (2017) -
GITR Activation Induces an Opposite Effect on Alloreactive CD4(+) and CD8(+) T Cells in Graft-Versus-Host Disease
por: Muriglan, Stephanie J., et al.
Publicado: (2004) -
Androgen receptor modulates Foxp3 expression in CD4(+)CD25(+)Foxp3(+) regulatory T-cells
por: Walecki, Magdalena, et al.
Publicado: (2015) -
CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells
por: Liu, Kechang, et al.
Publicado: (2011) -
The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancer
por: Jackute, Jurgita, et al.
Publicado: (2015)